Health economist. Assistant Professor @BrownHSPP
Joined May 2022
- Tweets 304
- Following 538
- Followers 257
- Likes 1,269
Photos and videos
Jeff Marr retweeted
TIL reading the Medicare Trustees Report: Medicare now spends more on outpatient care than hospital care.
4
12
28
4,257
Jeff Marr retweeted
Neil Mehta of @BrownUniversity and coauthors examine Rhode Island's 2010 affordability standards and find that hospital revenue reductions after price growth caps were implemented in the state resulted in reductions in hospital labor costs and staffing. healthaffairs.org/doi/10.137…
2
1
3
2,471
Jeff Marr retweeted
May 22
The rapid expansion of autism therapy for children has been driven by increased need, generous taxpayer-funded Medicaid payments, and private equity penetration, leading some companies to capitalize on the opportunity, at times outpacing regulatory oversight. | Forefront
@ysingh_phd, et al. | @Brown_SPH
healthaffairs.org/content/fo…
1
3
1
718
Jeff Marr retweeted
Broker enrollment in #MedicareAdvantage plans drove spending increases from $3.9 billion in 2014 to $10.1 billion in 2022, with most payments now attributed to renewal fees. ja.ma/4utWTSQ
1
3
1,047
Jeff Marr retweeted
Come work with us! Open rank faculty search for Vanderbilt's Department of Health Policy
jobs.academyhealth.org/job/a…
3
2
1,009
AI for claims review and prior authorization: Our new brief examines current consumer protections regarding AI’s use in health care — and how the Trump administration’s proposed AI framework could preempt some state’s protections.
🔗: on.kff.org/4uzhCV8
1
444
Jeff Marr retweeted
Among traditional #Medicare beneficiaries, private equity acquisition of primary care practices was not associated with changes in all-cause or preventable hospitalizations, but modestly reduced emergency department visits.
ja.ma/49Du7XA
ALT Graph: Differential Change in Hierarchical Condition Category Score, Private Equity (PE) and Matched Controls, 2016 to 2022. X axis: Quarters relative to acquisition (-6 to 6). Y axis: Coefficient (-0.02 to 0.02). Shows pretrend and treatment effects.
4
5
751
Jeff Marr retweeted
💬 Editorial: Most federal actions against #MedicareAdvantage plans involved low fines, with rare suspensions or terminations, emphasizing the need for improved oversight and a deeper understanding of plan quality and patient impact. ja.ma/4n5aahP
2
1
4
1,084
Jeff Marr retweeted
May 5
Layoffs in the Information sector (which includes much of tech) jumped in March, to their highest level on record outside the pandemic spike. Notable because the earlier wave of tech layoff announcements really didn't show up in the data.
2
6
25
18,764
Jeff Marr retweeted
Most federal enforcement against #MedicareAdvantage plans from 2010–2023 were modest monetary penalties, with suspensions or terminations affecting plans with lower star ratings and more minority or dual-eligible enrollees. ja.ma/3QLZpoH
2
2
797
Jeff Marr retweeted
May 4
New @JAMANetwork study! We document that non-profit hospitals have spent billions on management consultants and estimate the effects of this spending. In short, we find little statistically-discernible evidence of either major benefits or harms. (Some precise 0s, some wide CIs.)
1
3
12
1,198
Jeff Marr retweeted
The End-Stage Renal Disease Treatment Choices model by @CMSGov did not meaningfully increase use of home dialysis or kidney transplant among Medicare beneficiaries with #KidneyDisease after nearly 4 years of implementation.
ja.ma/4n8mluF
ALT Line graphs show trends in home dialysis, kidney transplant and transplant waitlist from 2017-2024. A: Home dialysis shows control regions trending up. B: Kidney transplant shows control regions fluctuating from 3.0-4.0. C: Transplant waitlist trending down.
1
139
Jeff Marr retweeted
“These are unbelievable increases,” an insurance broker said of rising premium costs for Medigap plans, which cover some Medicare payments for consumers. He's been in the business for 49 years.
@Julie_appleby reports ⤵️
kffhealthnews.org/medicare/m…
17
8
1,931
Jeff Marr retweeted
Most branded medication prescriptions initially rejected by prior authorization were delayed or denied, with lower approval rates among patients with Medicaid or multiple disease conditions, highlighting barriers to timely access for these populations. ja.ma/4vAvTC7
4
4
537
Jeff Marr retweeted
Mar 27
CMS’s proposed changes to the Medicare Advantage (MA) program have a strong basis in the empirical evidence and would reduce excess spending in MA. | Forefront
David J. Meyers, et al. | @Brown_SPH
healthaffairs.org/content/fo…
1
2
3
602
Jeff Marr retweeted
Mar 25
Starting in 2028, hospitals with off-campus sites must bill separately using distinct National Provider Identifier numbers. | Forefront
Jared Perkins, et al. | @Brown_SPH
healthaffairs.org/content/fo…
4
12
7,727
Jeff Marr retweeted
Mar 10
The average American senior’s Medicare premiums last year were about 10% higher, or more than $200 annually, because of alleged overpayments to private Medicare Advantage plans, congressional investigators found. 🔗 on.wsj.com/46OHz9Y
13
14
33
33,294
Jeff Marr retweeted
Mar 11
Disenrollment from an MA plan soon after enrollment may indicate dissatisfaction with plan benefits. @Brown_SPH's Em Balkan & coauthors examine trends of rapid disenrollment from MA & find that disenrollment increased from 3.5% in 2017 to 12.2% in 2022. healthaffairs.org/doi/full/1…
3
2
4,970
Jeff Marr retweeted
State laws prohibiting prior authorization for buprenorphine were not associated with significant changes in 180-day treatment retention among privately insured patients with #OpioidUseDisorder.
ja.ma/3ONtseR
ALT Forest plot illustrating difference-in-differences analysis of prior authorization prohibitions and 180-day buprenorphine treatment retention. Variables include 'Never treated as controls' and 'Not yet treated as controls', with corresponding adjusted estimates and P values.
1
137
Jeff Marr retweeted
Mar 4
Get excited! MedPAC's March 2026 Report to Congress will be released on Thursday, March 12th at 12:00 PM. The report will be posted on our website here: medpac.gov/
4
4
557